TLR4/NF-κB signaling pathway regulates inflammatory response involved in pathophysiological mechanisms of type A aortic dissection
10.7507/1007-4848.201811021
- VernacularTitle:TLR4/NF-κB 信号通路介导的血管炎症参与A 型主动脉夹层的发病机制
- Author:
LIN Zhenye
1
;
WANG Zhiwen
1
;
MENG Weixin
1
;
CHI Chao
1
;
ZHAN Xu
1
;
LIU Hongyu
1
Author Information
1. Department of Cardiac Vascular Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, P.R.China
- Publication Type:Journal Article
- Keywords:
Stanford type A aortic dissection;
immunity-inflammation;
toll-like receptors-4;
biomarker
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2019;26(8):748-753
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate activated toll-like receptor-4 (TLR4) signaling pathway involved in pathophysiological mechanisms of type A aortic dissection (TAAD). Methods Specimens of full-thickness ascending aorta wall from the TAAD patients (n=12) and the controlled donors (n=12) were collected. Western blotting was used to examine the associated proteins' expression of TLR4 signaling pathway. Blood samples from TAAD (n=43) and controlled patients (n=50) were examined by enzyme-linked immunosorbent assay (ELISA) to detect the circulating plasma cytokines levels of interleukin-1β (L-1β). Results In the aortic wall of TAAD, expression levels of TLR4 and protein expression of major molecule significantly elevated, and activated macrophages increased. Furthermore, elevated IL-1β levels were observed in the TAAD patients’ plasma compared with the control plasma. Multiple logistic regression analysis and receiver operating characteristic (ROC) curve showed that elevated IL-1β could be a novel and promising biomarker with important diagnostic and predictive value in the identification of TAAD. Conclusion Activated TLR4/NF-κB signaling pathway regulates inflammatory response to involve in pathophysiological mechanisms of type A aortic dissection and its regulated inflammatory products have important predictive value for patients with TAAD.